← FDA Drug Approvals (Drugs@FDA)

THIOTEPA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2024-08-20

Drug application

FDA Application #

ANDA217559

Application type

Abbreviated New Drug Application (Generic)

Brand name

THIOTEPA

Generic name

Thiotepa

Active ingredients

THIOTEPA

Dosage form

POWDER

Route

INTRACAVITARY, INTRAVENOUS, INTRAVESICAL

Marketing status

Prescription

Sponsor

REGCON HOLDINGS

First approval

2024-08-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown